EZR and ovarian carcinoma: ,88,89 An engineered OAV, Ad5/3-E2F-d24-vIL2, which encoded a variant IL-2 cytokine, stimulated high granzyme B production, selectively replicated, and destroyed tumor cells to enhance the effectiveness of TILs in ovarian cancer.89